HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Albiruni Abdul Razak Selected Research
Albiruni Abdul Razak Research Topics
Disease
3
Neoplasms (Cancer)
01/2020 - 01/2019
2
Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2024 - 12/2022
2
Nausea
01/2023 - 01/2022
2
Sarcoma (Soft Tissue Sarcoma)
01/2023 - 01/2022
1
Disease Progression
01/2024
1
Constipation
10/2023
1
Hand-Foot Syndrome
01/2023
1
Chondrosarcoma
01/2023
1
Ewing Sarcoma (Sarcoma, Ewing)
01/2023
1
Osteosarcoma (Osteogenic Sarcoma)
01/2023
1
Vomiting
01/2023
1
Mucositis
01/2023
1
Rhabdomyosarcoma
11/2022
1
Liposarcoma
01/2022
1
Fatigue
01/2022
Drug/Important Bio-Agent (IBA)
3
Sunitinib (Sutent)
FDA Link
01/2024 - 12/2022
3
ripretinib
IBA
01/2024 - 12/2022
2
Biomarkers (Surrogate Marker)
IBA
01/2024 - 01/2020
2
Imatinib Mesylate (Gleevec)
FDA Link
01/2024 - 12/2022
2
Tyrosine Kinase Inhibitors
IBA
01/2023 - 12/2022
2
pembrolizumab
IBA
01/2020 - 01/2020
2
Immune Checkpoint Inhibitors
IBA
01/2020 - 01/2019
1
cabozantinib
IBA
01/2023
1
regorafenib
IBA
01/2023
1
Bilirubin
IBA
01/2023
1
selinexor
IBA
01/2022
1
Circulating Tumor DNA
IBA
01/2020
Therapy/Procedure
1
Drug Tapering
01/2023
1
Aftercare (After-Treatment)
12/2022
1
Radiotherapy
11/2022
1
Immunotherapy
01/2019